Class Acts: Noah Kabbaj
Goldwater Scholar and biology major Noah Kabbaj is on the front lines of research aimed at helping people overcome treatment-resistant mental health conditions, including severe depression. After graduating from WashU, Kabbaj plans to earn his PhD in neuroscience.
Brain’s dynamics can be accurately tracked from a mouse’s eyes
WashU Medicine researchers led by Ryan Raut show that it is possible to accurately predict the state of brain activity by tracking variations in an animal’s pupil dilation, suggesting that brain circuits and the body are more dynamic and interrelated than previously thought.
Class Acts: Catalina Bernabé Correa
A passion for motorcycles and a background in neuroscience drove Catalina Bernabé Correa to join the lab of Ismael Seáñez at WashU McKelvey Engineering, where she is studying different neuro-rehabilitation strategies for individuals with spinal cord injuries. Bernabé is set to graduate in May with a bachelor’s degree in biomedical engineering.
Braver elected to American Academy of Arts & Sciences
WashU neuroscientist Todd Braver has been elected to the American Academy of Arts & Sciences, one of the nation’s most prestigious honorary societies.
Unique markers of neurodegenerative disease mapped in blood, spinal fluid
A study led by WashU Medicine researchers reveals molecular insights into Alzheimer’s disease, Parkinson’s disease and other dementias that could lead to earlier, more precise diagnoses.
Hengen wins NIH grant to study sleep’s role in Alzheimer’s treatment
Researchers at WashU have won $2.7 million from the National Institutes of Health (NIH) for a five-year investigation into the power of sleep to prevent, delay and diminish Alzheimer’s and other neurodegenerative diseases.
WashU launches doctoral program in neuroengineering
WashU will launch a doctoral program in neuroengineering in fall 2027, one of only a few in the United States.
Chemical compound clears cellular waste, protects neurons in model of frontotemporal dementia
New research from WashU Medicine adds to growing evidence that helping brain cells break down and eliminate their own cellular waste is a promising treatment strategy for a variety of neurodegenerative diseases.
Ackerman receives innovation in neuroscience award
Sarah Ackerman, at WashU Medicine, has been named a winner of the Maximizing Innovation in Neuroscience Discovery Prize by the Pershing Square Foundation.
Rogers honored for contributions to neurodevelopment
Cynthia Rogers, the Blanche F. Ittleson Professor of Psychiatry at WashU Medicine, has received the 2025 Joel Elkes Research Award from the American College of Neuropsychopharmacology for her research on early developmental markers of psychiatric risk associated with premature birth.
Older Stories